DOI QR코드

DOI QR Code

Inhibitory Effects of Panduratin A on Periodontitis-Induced Inflammation and Osteoclastogenesis through Inhibition of MAPK Pathways In Vitro

  • Kim, Haebom (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University) ;
  • Kim, Mi-Bo (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University) ;
  • Kim, Changhee (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University) ;
  • Hwang, Jae-Kwan (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University)
  • Received : 2017.07.18
  • Accepted : 2017.10.18
  • Published : 2018.02.28

Abstract

Periodontitis is an inflammatory disease caused by microbial lipopolysaccharide (LPS), destroying gingival tissues and alveolar bone in the periodontium. In the present study, we evaluated the anti-inflammatory and anti-osteoclastic effects of panduratin A, a chalcone compound isolated from Boesenbergia pandurata, in human gingival fibroblast-1 (HGF-1) and RAW 264.7 cells. Treatment of panduratin A to LPS-stimulated HGF-1 significantly reduced the expression of interleukin-$1{\beta}$ and nuclear factor-kappa B (NF-${\kappa}B$), subsequently leading to the inhibition of matrix metalloproteinase-2 (MMP-2) and MMP-8 compared with that in the LPS control ($^{**}p$ < 0.01). These anti-inflammatory responses were mediated by suppressing the mitogen-activated protein kinase (MAPK) signaling and activator protein-1 complex formation pathways. Moreover, receptor activator of NF-${\kappa}B$ ligand (RANKL)-stimulated RAW 264.7 cells treated with panduratin A showed significant inhibition of osteoclastic transcription factors such as nuclear factor of activated T-cells c1 and c-Fos as well as osteoclastic enzymes such as tartrate-resistant acid phosphatase and cathepsin K compared with those in the RANKL control ($^{**}p$ < 0.01). Similar to HGF-1, panduratin A suppressed osteoclastogenesis by controlling MAPK signaling pathways. Taken together, these results suggest that panduratin A could be a potential candidate for development as a natural anti-periodontitis agent.

Keywords

References

  1. Nibali L, Farias BC, Vajgel A, Tu YK, Donos N. 2013. Tooth loss in aggressive periodontitis: a systematic review. J. Dent. Res. 92: 868-875. https://doi.org/10.1177/0022034513501878
  2. Chapple ILC, Genco R, Working Group 2 of the Joint EFA/AAP Workshop. 2013. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J. Clin. Periodontol. 40: S106-S112. https://doi.org/10.1111/jcpe.12077
  3. Dietrich T, Sharma P, Walter C, Weston P, Beck J. 2013. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J. Clin. Periodontol. 40: S70-S84.
  4. Singhrao SK, Harding A, Poole S, Kesavalu L, Crean S. 2015. Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer's disease. Mediators Inflamm. 2015: 10.
  5. Herath TD, Darveau RP, Seneviratne CJ, Wang C-Y, Wang Y, Jin L. 2013. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-${\kappa}B$ signal transduction cascade and immunoinflammatory response in human gingival fibroblasts. PLoS One 8: e58496. https://doi.org/10.1371/journal.pone.0058496
  6. Bartold PM, Narayanan AS. 2006. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol. 2000 40: 29-49. https://doi.org/10.1111/j.1600-0757.2005.00140.x
  7. Ko S Y. 2012. Myricetin sup pesrses L PS-induced M MP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKLtreated RAW 264.7 cells. Arch. Oral Biol. 57: 1623-1632.
  8. Hienz SA, Paliwal S, Ivanovski S. 2015. Mechanisms of bone resorption in periodontitis. J. Immunol. Res. 2015: 615486.
  9. He L, Duan H, Li X, Wang S, Zhang Y, Lei L, et al. 2016. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis. Eur. J. Pharmacol. 779: 66-79.
  10. Wada T, Nakashima T, Hiroshi N, Penninger JM. 2006. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12: 17-25. https://doi.org/10.1016/j.molmed.2005.11.007
  11. Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, et al. 2005. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202: 1261-1269. https://doi.org/10.1084/jem.20051150
  12. Kim MS, Pyun HB, Hwang JK. 2013. Effects of orally administered fingerroot (Boesenbergia pandurata) extract on oxazolone-induced atopic dermatitis-like skin lesions in hairless mice. Food Sci. Biotechnol. 22: 257-264.
  13. Park KM, Choo JH, Sohn JH, Lee SH, Hwang JK. 2005. Antibacterial activity of panduratin A isolated from Kaempferia pandurata against Porphyromonas gingivalis. Food Sci. Biotechnol. 14: 286-289.
  14. Yanti, Rukayadi Y, Lee KH, Hwang JK. 2009. Activity of panduratin A isolated from Kaempferia pandurata Roxb. against multi-species oral biofilms in vitro. J. Oral Sci. 51: 87-95. https://doi.org/10.2334/josnusd.51.87
  15. Yanti, Oh HI, Anggakusuma, Hwang JK. 2009. Effects of panduratin A isolated from Kaempferia pandurata ROXB. on the expression of matrix metalloproteinase-9 by Porphyromonas gingivalis supernatant-induced KB cells. Biol. Pharm. Bull. 32: 110-115. https://doi.org/10.1248/bpb.32.110
  16. Shim JS, Kwon YY, Han YS, Hwang JK. 2008. Inhibitory effect of panduratin A on UV-induced activation of mitogenactivated protein kinases (MAPKs) in dermal fibroblast cells. Planta Med. 74: 1446-1450. https://doi.org/10.1055/s-2008-1081352
  17. He Y, Zhang Q, Shen Y, Chen X, Zhou F, Peng D. 2014. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways. Biochem. Biophys. Res. Commun. 449: 344-350. https://doi.org/10.1016/j.bbrc.2014.05.034
  18. Gomez-Florit M, Monjo M, Ramis JM. 2015. Quercitrin for periodontal regeneration: effects on human gingival fibroblasts and mesenchymal stem cells. Sci. Rep. 5: 16593. https://doi.org/10.1038/srep16593
  19. Maeso G, Bravo M, Bascones A. 2007. Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingiva. Quintessence Int. 38: 247-252.
  20. Rai B, Kaur J, Jain R, Anand SC. 2010. Levels of gingival crevicular metalloproteinases-8 and -9 in periodontitis. Saudi Dent. J. 22: 129-131. https://doi.org/10.1016/j.sdentj.2010.04.006
  21. Kida Y, Kobayashi M, Suzuki T, Takeshita A, Okamatsu Y, Hanazawa S, et al. 2005. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine 29: 159-168. https://doi.org/10.1016/j.cyto.2004.10.009
  22. Yanti, Lee M, Kim D, Hwang JK. 2009. Inhibitory effect of panduratin A on c-Jun N-terminal kinase and activator protein-1 signaling involved in Porphyromonas gingivalis supernatant-stimulated matrix metalloproteinase-9 expression in human oral epidermoid cells. Biol. Pharm. Bull. 32: 1770-1775. https://doi.org/10.1248/bpb.32.1770
  23. Baek JM, Kim JY, Cheon YH, Park SH, Ahn SJ, Yoon KH, et al. 2014. Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone loss in mice. Molecules 19: 11628-11644. https://doi.org/10.3390/molecules190811628
  24. Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, et al. 2007. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259. https://doi.org/10.1182/blood-2006-09-048249
  25. Gutierrez-Venegas G, Luna OA, Arreguin-Cano JA, Hernandez-Bermudez C. 2014. Myricetin blocks lipoteichoic acid-induced COX-2 expression in human gingival fibroblasts. Cell. Mol. Biol. Lett. 19: 126-139.
  26. Xagorari A, Roussos C, Papapetropoulos A. 2002. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br. J. Pharmacol. 136: 1058-1064. https://doi.org/10.1038/sj.bjp.0704803

Cited by

  1. Inhibitory Effects of Boesenbergia pandurata on Age-Related Periodontal Inflammation and Alveolar Bone Loss in Fischer 344 Rats vol.28, pp.3, 2018, https://doi.org/10.4014/jmb.1711.11034
  2. Inhibitory Effects of Curcuma xanthorrhiza Supercritical Extract and Xanthorrhizol on LPS-Induced Inflammation in HGF-1 Cells and RANKL-Induced Osteoclastogenesis in RAW264.7 Cells vol.28, pp.8, 2018, https://doi.org/10.4014/jmb.1803.03045
  3. 4-Hydroxypanduratin A and Isopanduratin A Inhibit Tumor Necrosis Factor α-Stimulated Gene Expression and the Nuclear Factor κB-Dependent Signaling Pathway in Human Lung Adenocarcinoma A549 vol.42, pp.1, 2018, https://doi.org/10.1248/bpb.b18-00457
  4. Protective Effect of Panduratin A on Cisplatin-Induced Apoptosis of Human Renal Proximal Tubular Cells and Acute Kidney Injury in Mice vol.44, pp.6, 2018, https://doi.org/10.1248/bpb.b21-00036
  5. Periodontal Inflammation and Systemic Diseases: An Overview vol.12, pp.None, 2018, https://doi.org/10.3389/fphys.2021.709438
  6. Chalcone T4, a novel chalconic compound, inhibits inflammatory bone resorption in vivo and suppresses osteoclastogenesis in vitro vol.56, pp.3, 2018, https://doi.org/10.1111/jre.12857
  7. Synergistic Effect of Biphasic Calcium Phosphate and Platelet-Rich Fibrin Attenuate Markers for Inflammation and Osteoclast Differentiation by Suppressing NF-κB/MAPK Signaling Pathway in Chronic vol.26, pp.21, 2018, https://doi.org/10.3390/molecules26216578